Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Claire Brulle-Wohlhueter

A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2018English

Related publications

Pdb86 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Bulgaria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People With Type 2 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2016English

Pdb79 - Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients With Type 2 Diabetes Mellitus in Croatia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Degludec in Patients With Type 2 Diabetes: A Randomized, Open-Label, Crossover Study Using Continuous Glucose Monitoring Profiles

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

New Insulin Glargine 300 Units{middle Dot}mL-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units{middle Dot}mL-1

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

In Silico Head-To-Head Comparison of Insulin Glargine 300 U/Ml and Insulin Degludec 100 U/Ml in Type 1 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL−1 and Glargine 100 U mL−1 in Japanese People With Type 1 Diabetes Mellitus: A Crossover Pilot Study

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Comparable Glycaemic Control and Hypoglycaemia in Adults With Type 2 Diabetes After Initiating Insulin Glargine 300 Units/mL or Insulin Degludec: DELIVER Naïve D Real‐world Study

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Achieve Control: A Pragmatic Clinical Trial of Insulin Glargine 300 U/mL Versus Other Basal Insulins in Insulin-Naïve Patients With Type 2 Diabetes

Postgraduate Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy